Please login to the form below
Medical Translations: Why you need to get it right the first time
British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors.
Read the full report here.
This study of US and UK based senior executives with an international role in medical research, clinical trials or pharmaceuticals shows that almost all understand the difference between translation and localisation, and are acutely aware that the misuse of cultural references or linguistic errors could lead to crisis communications or damage to their companies’ brand reputation.
Almost half of our respondents localise rather than translate more than 40% of their medical content and 39% have noticed an increase in consumer engagement and sales due to properly localised content.
Revision is paramount when it comes to content within the life sciences sector. Most cultural references and linguistic interpretations are defined and refined during the revision stage. 83% of all those who participated in the survey have in-country linguists reviewing the localised content for market appropriateness and 78% run user testing on localised content prior to release.
While 76% admit to having experienced a cultural faux pas due to a mistreated/wrong cultural reference, most of our respondents (85%) are confident that the content they are producing is suitable for the intended target audience or culture.72% of all our respondents agreed that interactions with their target markets have been adversely impacted by inappropriately localised content.
The main repercussions of misinterpreted or mistranslated content appear to be:
These results are not only of importance to the medical industry, but those working in translation and localisation will also find them valuable given that 73% of all respondents agreed that they have a need, within their company, for support from a Language Service Provider.
Read the full report here.
This study of US and UK based senior executives with an international role in medical research, clinical trials or pharmaceuticals shows that almost all understand the difference between translation and localisation, and are acutely aware that the misuse of cultural references or linguistic errors could lead to crisis communications or damage to their companies’ brand reputation.
Almost half of our respondents localise rather than translate more than 40% of their medical content and 39% have noticed an increase in consumer engagement and sales due to properly localised content.
Revision is paramount when it comes to content within the life sciences sector. Most cultural references and linguistic interpretations are defined and refined during the revision stage. 83% of all those who participated in the survey have in-country linguists reviewing the localised content for market appropriateness and 78% run user testing on localised content prior to release.
While 76% admit to having experienced a cultural faux pas due to a mistreated/wrong cultural reference, most of our respondents (85%) are confident that the content they are producing is suitable for the intended target audience or culture.72% of all our respondents agreed that interactions with their target markets have been adversely impacted by inappropriately localised content.
The main repercussions of misinterpreted or mistranslated content appear to be:
- inaccuracy and inconsistency in global communications
- a global crisis communication
- damage to global partnerships
- damage to company image and reputation
- delays in delivering the campaign/project
- profit loss
These results are not only of importance to the medical industry, but those working in translation and localisation will also find them valuable given that 73% of all respondents agreed that they have a need, within their company, for support from a Language Service Provider.
Read the full report here.
Company Details
Conversis
+44 (0)1869255820
Address:
Bignell Park Barns
Chesterton
Bicester
Oxfordshire
OX26 1TD
United Kingdom
Latest content on this profile
- Medical Translations: Why you need to get it right the first time
- British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors.
Conversis
- Avoiding PR Disaster: Cultural Customisation
Conversis
- 10 tips on Transcreation
- We have put together a few pointers that you should consider for the process of transcreation.
Conversis
- Top 10 tips for Translation in Medical Communications
- Accuracy and high-quality should be the most important decision factors when choosing your medical translations partner as there is no room for mistakes or ambiguities.
Conversis
- How do you ensure your communication will excite and interest your patients
- This is an opinion article on how to keep your patients interested and on board through the full clinical study
Conversis
- What it takes to win at Cannes Health Lions
- A podcast featuring our Director, Russell Goldsmith, talking with two judges of the Lions Health Awards, Zuleika Burnett, Executive Director for Creative and Innovation at Havas Life Medicom and Martin Hafley, Creative Director at DDB Remedy London, together with a past Bronze winner, Khalid Latiff, Associate Creative Director at Publicis Life Brands Resolute (PLBR), whose company also picked up a Silver and Bronze this year too.
Conversis
